1129

Mary Tyler Moore

Currency:USD Category:Collectibles / Autographs Start Price:NA Estimated At:100.00 - 300.00 USD
Mary Tyler Moore

Bidding Over

The auction is over for this lot.
The auctioneer wasn't accepting online bids for this lot.

Contact the auctioneer for information on the auction results.

Search for other lots to bid on...
Auction Date:2020 Oct 24 @ 18:00 (UTC-5 : EST/CDT)
Location:15th Floor WeWork, Boston, Massachusetts, 02108, United States
ALS - Autograph Letter Signed
ANS - Autograph Note Signed
AQS - Autograph Quotation Signed
AMQS - Autograph Musical Quotation Signed
DS - Document Signed
FDC - First Day Cover
Inscribed - “Personalized”
ISP - Inscribed Signed Photograph
LS - Letter Signed
SP - Signed Photograph
TLS - Typed Letter Signed
TLS, two pages, 8.5 x 11, JDF International, The Diabetes Research Foundation letterhead, May 15, 1989. Letter to longtime Kentucky Congressman William Natcher, in part: "I would like to take this opportunity to thank you for your warm hospitality and your continued support for a strong federal diabetes research program. From the delightful luncheon to your warm welcoming remarks to your kind comments about my testimony, you made my day in Washington one of the most memorable ever. Your commitment to use a healthier America through a strong NIH is profound, wise, and inspiring. As I reflect upon the great progress we have made in ameliorating diabetes and its complications over the past decade—the insulin pump, human insulin, laser therapy to arrest diabetes-induced blindness, improved care for pregnant diabetics, diabetic islet cell transplantation—I know where to look to express my gratitude…I believe that the request of the Juvenile Diabetes Foundation, the American Diabetes Association, and the National Kidney Foundation for a special $5 million appropriation for basic research into diabetic kidney disease is a wise investment. Death from kidney disease is 500 times more common among young adults with insulin-dependent diabetes than in the general population. Diabetics comprise approximately 30 percent of patients in the $3 billion End Stage Renal Disease program. By the mid-1990s, diabetics will account for one-half of all dialysis patients. This is a tragedy of staggering dimension and we feel that, in the absence of a 'set-aside' of funds for this important research endeavor, NIH will be unable to intensify its battle against one of the most severe diabetic complications. I hope that you will give our request your most serious consideration…I hope that you will not mind if I periodically check in with you to chat and ascertain the status of the important issues we discussed. If ever I can be of assistance to you, please do not hesitate to let me know." In fine condition. Moore, herself a diabetic, was International Chairman of the Juvenile Diabetes Research Foundation and used her celebrity status to help raise funds and awareness of the disease.